Balance Sheet Merchavia Holdings and Investments Ltd
Equities
MRHL
IL0002570146
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175.30 ILa | +0.46% |
|
+3.48% | -18.65% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 7.43M | 4.08M | 2.2M | 1.38M | 352K | |||||
Short Term Investments | - | 172K | - | - | - | |||||
Total Cash And Short Term Investments | 7.43M | 4.25M | 2.2M | 1.38M | 352K | |||||
Other Receivables | 408K | 331K | 245K | 172K | 316K | |||||
Notes Receivable | - | - | - | - | - | |||||
Total Receivables | 408K | 331K | 245K | 172K | 316K | |||||
Prepaid Expenses | 4K | 13K | 14K | 14K | 16K | |||||
Other Current Assets, Total | 6K | - | - | 16K | 50K | |||||
Total Current Assets | 7.85M | 4.59M | 2.46M | 1.58M | 734K | |||||
Net Property Plant And Equipment | 12K | 13K | 16K | 8K | 1K | |||||
Long-term Investments | 40.08M | 40.62M | 27.16M | 21.3M | 15.1M | |||||
Loans Receivable Long-Term | 554K | 533K | 499K | 2M | 2M | |||||
Other Long-Term Assets, Total | 225K | - | - | - | - | |||||
Total Assets | 48.72M | 45.76M | 30.12M | 24.89M | 17.83M | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 378K | 326K | 438K | 412K | 530K | |||||
Accrued Expenses, Total | 348K | 372K | 661K | 913K | 1.13M | |||||
Short-term Borrowings | - | - | - | - | 751K | |||||
Current Portion of Long-Term Debt | - | - | - | - | - | |||||
Unearned Revenue Current, Total | - | - | 80K | 120K | - | |||||
Other Current Liabilities | 92K | 144K | 48K | 49K | 49K | |||||
Total Current Liabilities | 818K | 842K | 1.23M | 1.49M | 2.46M | |||||
Other Non Current Liabilities | 45K | - | - | - | - | |||||
Total Liabilities | 863K | 842K | 1.23M | 1.49M | 2.46M | |||||
Common Stock, Total | 12.88M | 12.88M | 12.88M | - | - | |||||
Additional Paid In Capital | 35.18M | 35.84M | 36.05M | 50.41M | 52.54M | |||||
Retained Earnings | 1.1M | -2.5M | -18.74M | -25.71M | -35.87M | |||||
Treasury Stock | -1.3M | -1.3M | -1.3M | -1.3M | -1.3M | |||||
Comprehensive Income and Other | - | - | - | - | - | |||||
Total Common Equity | 47.86M | 44.91M | 28.9M | 23.4M | 15.38M | |||||
Total Equity | 47.86M | 44.91M | 28.9M | 23.4M | 15.38M | |||||
Total Liabilities And Equity | 48.72M | 45.76M | 30.12M | 24.89M | 17.83M | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 16.43M | 16.8M | 16.8M | 17.8M | 21M | |||||
ECS Total Common Shares Outstanding | 16.43M | 16.8M | 16.8M | 17.8M | 21M | |||||
Book Value / Share | 2.91 | 2.67 | 1.72 | 1.31 | 0.73 | |||||
Tangible Book Value | 47.86M | 44.91M | 28.9M | 23.4M | 15.38M | |||||
Tangible Book Value Per Share | 2.91 | 2.67 | 1.72 | 1.31 | 0.73 | |||||
Total Debt | 0 | 0 | 0 | 0 | 751K | |||||
Net Debt | -7.43M | -4.25M | -2.2M | -1.38M | 399K | |||||
Equity Method Investments, Total | - | - | - | - | - | |||||
Account Code - Inventory Valuation | 3 | 3 | 3 | 3 | 3 | |||||
Full Time Employees | 1 | 1 | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
















